Cell Growth & Differentiation, Vol 3, Issue 12 873-879, Copyright © 1992 by American Association of Cancer Research

ARTICLES

Embryonic expression of nm23 during mouse organogenesis

M Lakso, PS Steeg and H Westphal
Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

Nonmetastatic (nm) 23 gene expression correlates inversely with metastatic potential in several rodent tumor model systems as well as in human infiltrating ductal breast and hepatocellular carcinomas. Since tumor cell invasion and metastasis involve many processes exhibited by normal cells during development, we investigated whether nm23 is expressed during mouse embryogenesis. Northern blot analysis of embryonic RNAs showed that nm23 gene transcription occurs widely during embryogenesis. Immunohistochemical analysis demonstrated that, at the onset of organogenesis, the amount of Nm23 protein is relatively low and uniform throughout the embryo. On embryonic day E10.5, the protein begins to accumulate preferentially in the developing nervous system and heart, the first embryonic tissues to differentiate. Subsequent differentiation of liver, kidney, skin, intestine, adrenal, and stomach (but not lung) epithelial cells during embryonic development is accompanied by increased Nm23 protein expression. Although most tissues retain Nm23 protein levels to adult life, the increase is transient in intestinal epithelia and cyclic in adult mammary tissue during pregnancy and lactation. We conclude that Nm23 protein accumulation is coincident with the functional differentiation of multiple epithelial tissues in the developing mouse.

This article has been cited by other articles:

				S. Y. Kim, J. E. Ferrell Jr., S.-K. Chae, and K.-J. Lee Inhibition of Progesterone-induced Xenopus Oocyte Maturation by Nm23 Cell Growth Differ., September 1, 2000; 11(9): 485 - 490. [Abstract] [Full Text]

				N.-H. Chow, H.-S. Liu, and S.-H. Chan The Role of nm23-H1 in the Progression of Transitional Cell Bladder Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3595 - 3599. [Abstract] [Full Text]

				H. Miyazaki, M. Fukuda, Y. Ishijima, Y. Takagi, T. Iimura, A. Negishi, R. Hirayama, N. Ishikawa, T. Amagasa, and N. Kimura Overexpression of nm23-H2/NDP Kinase B in a Human Oral Squamous Cell Carcinoma Cell Line Results in Reduced Metastasis, Differentiated Phenotype in the Metastatic Site, and Growth Factor-independent Proliferative Activity in Culture Clin. Cancer Res., December 1, 1999; 5(12): 4301 - 4307. [Abstract] [Full Text] [PDF]

				S.M. Quenby, M.R. Gazvani, C. Brazeau, J. Neilson, D.I. Lewis-Jones, and G. Vince Oncogenes and tumour suppressor genes in first trimester human fetal gonadal development Mol. Hum. Reprod., August 1, 1999; 5(8): 737 - 741. [Abstract] [Full Text] [PDF]

				R. Willems, D. R. Van Bockstaele, F. Lardon, M. Lenjou, G. Nijs, H.-W. Snoeck, Z. N. Berneman, and H. Slegers Decrease in Nucleoside Diphosphate Kinase (NDPK/nm23) Expression during Hematopoietic Maturation J. Biol. Chem., May 29, 1998; 273(22): 13663 - 13668. [Abstract] [Full Text] [PDF]

				E. F. Michelotti, S. Sanford, J. M. P. Freije, N. J. MacDonald, P. S. Steeg, and D. Levens Nm23/PuF Does Not Directly Stimulate Transcription through the CT Element in Vivo J. Biol. Chem., September 5, 1997; 272(36): 22526 - 22530. [Abstract] [Full Text] [PDF]

				P. D. Wagner, P. S. Steeg, and N.-D. Vu Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity PNAS, August 19, 1997; 94(17): 9000 - 9005. [Abstract] [Full Text] [PDF]

				J. M.P. Freije, P. Blay, N. J. MacDonald, R. E. Manrow, and P. S. Steeg Site-directed Mutation of Nm23-H1. MUTATIONS LACKING MOTILITY SUPPRESSIVE CAPACITY UPON TRANSFECTION ARE DEFICIENT IN HISTIDINE-DEPENDENT PROTEIN PHOSPHOTRANSFERASE PATHWAYS IN VITRO J. Biol. Chem., February 28, 1997; 272(9): 5525 - 5532. [Abstract] [Full Text] [PDF]

				N. Ishikawa, H. Taniguchi-Seto, Y. Munakata, Y. Takagi, N. Shimada, and N. Kimura Multiple Transcripts for Rat Nucleoside Diphosphate Kinase alpha Isoform Are Structurally Categorized into Two Groups That Exhibit Cell-specific Expression and Distinct Translation Potential J. Biol. Chem., February 7, 1997; 272(6): 3289 - 3295. [Abstract] [Full Text] [PDF]

				W.-W. Lai, M.-H. Wu, J.-J. Yan, and F.-F. Chen Immunohistochemical Analysis of nm23-H1 in Stage I Non-Small Cell Lung Cancer: A Useful Marker in Prediction of Metastases Ann. Thorac. Surg., November 1, 1996; 62(5): 1500 - 1504. [Abstract] [Full Text]

				E. Postel, S. Berberich, S. Flint, and C. Ferrone Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis Science, July 23, 1993; 261(5120): 478 - 480. [Abstract] [PDF]

				P. D. Wagner and N.-D. Vu Phosphorylation of Geranyl and Farnesyl Pyrophosphates by Nm23 Proteins/Nucleoside Diphosphate Kinases J. Biol. Chem., November 3, 2000; 275(45): 35570 - 35576. [Abstract] [Full Text] [PDF]